High-throughput investigation of cyclin docking interactions reveals the complexity of motif binding determinants
Many regulatory protein-protein interactions depend on Short Linear Motifs (SLiMs). In the cell cycle, cyclin-CDKs recognize SLiMs to control substrate recruitment and phosphorylation timing. Here, we measure the relative binding strength of ~100,000 peptides to 11 human cyclins from five families (D, E, A, B, and F). Using a quantitative intracellular binding assay and large-scale tiled peptide screening, we identify multiple non-canonical binders unveiling a broader repertoire of cyclin docking motif types. Cryo-electron microscopy and saturation mutagenesis studies reveal distinct binding modes and sequence features governing motif recognition, binding strength, and cyclin preference. Docking motifs vary from highly selective to pan-cyclin, thereby fine-tuning the timing of CDK phosphorylation during cell cycle. Overall, these findings provide insights into the rules encoding specificity and affinity of SLiM-mediated interactions and offer a framework for understanding motif-driven protein networks across the proteome.
Authors
- Peter M. Pryciak (ORCID: https://orcid.org/0000-0001-9142-1369)
- Natàlia de Martín Garrido (ORCID: https://orcid.org/0000-0001-7175-5919)
- Caroline Benz (ORCID: https://orcid.org/0000-0002-5166-3598)
- Matthew J. Winters
- Mihkel Örd (ORCID: https://orcid.org/0000-0003-0454-7241)
- Ylva Ivarsson (ORCID: https://orcid.org/0000-0002-7081-3846)
- Victoria I. Cushing (ORCID: https://orcid.org/0000-0002-7976-0859)
- Johanna Kliche (ORCID: https://orcid.org/0000-0003-3179-4635)
- Basil J. Greber (ORCID: https://orcid.org/0000-0001-9379-7159)
- Norman E. Davey (ORCID: https://orcid.org/0000-0001-6988-4850)
- Mythili S. Subbanna
Institutions
- Uppsala University (SE)
- Institute of Cancer Research (GB)
- University of Massachusetts Chan Medical School (US)
- University of Cambridge (GB)
- Danish Cancer Society (DK)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1038/s41467-025-62765-z
- Citations
- 8
- Primary Topic
- Ubiquitin and proteasome pathways
- Type
- article
- Field-Weighted Citation Impact
- 6.45
Funders
- UK Research and Innovation
- Cancer Research UK
- Boehringer Ingelheim Fonds
- Vetenskapsrådet
- National Institutes of Health
- Medical Research Council